In 2019, the Japanese Circulation Society published 2 guidelines in the field of coronary
artery disease (CAD):(1) a guideline for acute coronary syndrome (ACS) that integrated …

Multiple guidelines and consensus papers have addressed the role of antithrombotic
strategies in patients with established coronary artery disease (CAD). Since evidence and …

This chapter about antithrombotic therapy for coronary artery disease is part of the
Antithrombotic and Thrombolytic Therapy: American College of Chest Physicans Evidence …

This chapter about antithrombotic therapy for coronary artery disease (CAD) is part of the
Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy: Evidence Based …

Antiplatelet therapy (APT) has become an important tool in the treatment and prevention of
atherosclerotic events, particularly those associated with coronary artery disease. A large …

The aim of this collaborative document is to provide an update for clinicians on best
antithrombotic strategies in patients with aortic and/or peripheral arterial diseases …

Background Several new antithrombotic therapies have emerged for the treatment of acute
coronary syndrome (ACS). We sought to assess contemporary patterns of antithrombotic …

Following an acute coronary syndrome (ACS), heightened predisposition to
atherothrombotic events may persist for years. Advances in understanding the pathobiology …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive evidence review was conducted through November 2010, as well as selected …

Importance Antithrombotic treatment in patients with atrial fibrillation (AF) and percutaneous
coronary intervention (PCI) presents a balancing act with regard to bleeding and ischemic …